A detailed history of Xtx Topco LTD transactions in Fibrogen Inc stock. As of the latest transaction made, Xtx Topco LTD holds 18,332 shares of FGEN stock, worth $6,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,332
Previous 475,716 96.15%
Holding current value
$6,416
Previous $423,000 98.35%
% of portfolio
0.0%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.33 - $1.26 $150,936 - $576,303
-457,384 Reduced 96.15%
18,332 $7,000
Q2 2024

Aug 12, 2024

BUY
$0.89 - $2.36 $423,387 - $1.12 Million
475,716 New
475,716 $423,000
Q4 2023

Feb 13, 2024

SELL
$0.38 - $0.91 $43,024 - $103,032
-113,222 Reduced 64.89%
61,274 $54,000
Q3 2023

Nov 13, 2023

BUY
$0.79 - $2.83 $126,212 - $452,129
159,763 Added 1084.39%
174,496 $150,000
Q2 2023

Aug 14, 2023

BUY
$2.49 - $20.59 $36,685 - $303,352
14,733 New
14,733 $39,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.